|
|
|
| home > white papers > Clinical Trial Labelling – More Than Just Labels - Faubel & Co. Nachfolger GmbH |
|
|
 WHITE PAPERS |
|
Faubel & Co. Nachfolger GmbH
|
|
Clinical Trial Labelling – More Than Just Labels
|
|
Deciding which label is best for a particular trial project is not always easy. Labels have become multifunctional tools which are able to convey variable data in different languages, indicate first opening, product originality, support ease of use or blind study drugs. They are no longer used as mere carriers of specified contents.
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
New to the PPMA Show 2018: Bright Ideas - Ambassador Programme
A new initiative for PPMA Show visitors this year is the Bright Ideas -
Ambassador Programme - a free advice service for start-up ventures and
entrepreneurs.
More info >> |
|
 |
White Papers |
 |
|
Achieve full compliance with tamper-verification pharma solutions
UPM Raflatac
UPM Raflatac has developed a range of pharmaceutical labelling products to support compliance with the Falsified Medicines Directive on packaging for prescription drugs and high-risk, over-the-counter medicines. Few solutions offer the same ease of adoption for meeting the February 2019 deadline.
More info >> |
|
 |
Industry Events |
 |
Clinical Trial Supply East coast 2018
16-17 October 2018, King of Prussia, PA
This unique event brings together leading pharma, device and
biotech professionals from across the East Coast region, to collaboratively
enhance the clinical supply chain. Over the two days, delegates and speakers
will discuss how to select forecasting and planning technology, how to reduce
waste in clinical trials supplies, how to choose your packaging strategy, but
we will also discover all the new technologies that will disrupt your clinical
trials supplies.
More info >> |
|
|
|
